The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 383.50
Bid: 388.00
Ask: 390.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.515%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 383.50
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Announcement: AGM Notice of call

27 Feb 2020 16:20

RNS Number : 4017E
Banco Santander S.A.
27 February 2020
 

 

Banco Santander, S.A. (the "Bank" or "Santander"), in compliance with the Securities Market legislation, hereby communicates the following:

OTHER RELEVANT INFORMATION

AGM call

The board of directors of the Bank at its meeting held today, resolved to call shareholders to the next ordinary general shareholders' meeting (the "2020 AGM") to be held in Santander, at the Palacio de Exposiciones y Congresos (Avenida del Racing, s/n), on 2 April 2019 at 9:30 a.m. on first call, or on 3 April 2019, at the same time and place, on second call, with the agenda indicated below.

Changes in the board of directors

The board, following a proposal of its appointments committee, has resolved to submit to the 2020 AGM the appointment of Mr. Sergio Agapito Lires Rial as new executive director. Mr. Rial, who joined the Santander Group in 2015, will maintain his current position as country head for the Group in Brazil, head of South America and head of Global Trade Services (GTS), the platform Santander is developing to facilitate international trade for SMEs, and will continue to report to the CEO of Banco Santander, José Antonio Álvarez.

Since joining Santander, Mr. Sergio Rial has led Santander Brazil's transformation, with RoTE increasing from 14.1% in 2015 to 21.2% in 2019. In addition to his knowledge of Brazil and Latin America, Mr. Rial brings broad international experience and a long track record in both banking and other businesses, having held senior positions in ABN AMRO (CEO for Asia and member of the global ExCo), Bear Stearns, Marfrig (CEO), Cargill (Executive Vice-President and CFO). He has also been a member of the board of other major Brazilian and non-Brazilian companies.

Mr Sergio Rial will fill the vacancy left by Mr Ignacio Benjumea Cabeza de Vaca, who, after five years as director and having been previously general secretary and secretary of the Board, has notified his decision not to submit his re-election to the approval of the 2020 AGM, as would be required under the board renovation by thirds provided for in the Bylaws, and to cease in his office with effect from the moment Mr Rial takes office.

In addition, as announced on 26 November 2019, the board has resolved to propose to the 2020 AGM the appointment of Mr Luis Isasi Fernández de Bobadilla, as external, filling in the vacancy left by Mr Guillermo de la Dehesa. Mr Luis Isasi will provide to the Board his strong Experience in financial services, banking industry (both in commercial and investment banking), and capital markets.

Both Mr. Isasi and Mr. Rial's appointment are also subject to regulatory approval.

Agenda for the 2020 AGM

One.- Annual accounts and corporate management.

One A. Examination and, if appropriate, approval of the annual accounts (balance sheet, profit and loss statement, statement of recognised income and expense, statement of changes in total equity, cash flow statement, and notes) and the directors' reports of Banco Santander, S.A. and its consolidated Group, all with respect to the Financial Year ended 31 December 2019.

One B. Examination and, if appropriate, approval of the consolidated statement of non-financial information for the Financial Year ended 31 December 2019 and which is part of the consolidated directors' report.

One C. Examination and, if appropriate, approval of the corporate management for Financial Year 2019.

Two.- Application of results obtained during Financial Year 2019.

Three.- Board of directors: appointment, re-election or ratification of directors.

Three A. Setting of the number of directors.

Three B. Appointment of Mr Luis Isasi Fernández de Bobadilla.

Three C. Appointment of Mr Sergio Agapito Lires Rial.

Three D. Ratification of the appointment and re-election of Mrs Pamela Ann Walkden.

Three E. Re-election of Ms Ana Patricia Botín-Sanz de Sautuola y O'Shea.

Three F. Re-election of Mr Rodrigo Echenique Gordillo.

Three G. Re-election of Ms Esther Giménez-Salinas i Colomer.

Three H. Re-election of Ms Sol Daurella Comadrán.

Four.- Re-election of the external auditor for Financial Year 2020.

Five.- Authorisation for the Bank and its subsidiaries to acquire treasury shares pursuant to the provisions of sections 146 and 509 of the Spanish Capital Corporations Law, depriving of effect, to the extent not used, the authorisation granted by resolution Five II) of the shareholders acting at the ordinary general shareholders' meeting of 12 April 2019.

Six.- Authorisation to the board of directors such that, pursuant to the provisions of section 297.1.b) of the Spanish Capital Corporations Law, it may increase the share capital on one or more occasions and at any time, within a period of three years, by means of cash contributions and by a maximum nominal amount of 4,154,528,645.50 euros, all upon such terms and conditions as it deems appropriate, depriving of effect, to the extent of the unused amount, the authorisation granted under resolution Seven II) adopted at the ordinary general shareholders' meeting of 23 March 2018. Delegation of the power to exclude pre-emptive rights, as provided by section 506 of the Spanish Capital Corporations Law.

Seven.-

Seven A.- Increase in share capital by such amount as may be determined pursuant to the terms of the resolution, by means of the issuance of new ordinary shares having a par value of one-half (0.5) euro each, with no share premium, of the same class and series as those that are currently outstanding, with a charge to reserves. Offer to acquire bonus share rights (derechos de asignación gratuita) at a guaranteed price and power to use, for such purpose, voluntary reserves from retained earnings or share premium, depriving of effect the resolution Six adopted at the ordinary general shareholders' meeting of 12 April 2019. Express provision for the possibility of less than full allotment. Delegation of powers to the board of directors, which may in turn delegate such powers to the executive committee, to establish the terms and conditions of the increase as to all matters not provided for by the shareholders at this general meeting, to take such actions as may be required for implementation thereof, to amend the text of sections 1 and 2 of article 5 of the Bylaws to reflect the new amount of share capital, and to execute such public and private documents as may be necessary to carry out the increase. Application to the appropriate domestic and foreign authorities for admission to trading of the new shares on the Madrid, Barcelona, Bilbao and Valencia Stock Exchanges through Spain's Automated Quotation System (Mercado Continuo) and on the foreign Stock Exchanges on which the shares of Banco Santander are listed in the manner required by each of such Stock Exchanges.

Seven B.- Increase in share capital by such amount as may be determined pursuant to the terms of the resolution, by means of the issuance of new ordinary shares having a par value of one-half (0.5) euro each, with no share premium, of the same class and series as those that are currently outstanding, with a charge to reserves. Offer to acquire bonus share rights (derechos de asignación gratuita) at a guaranteed price and power to use, for such purpose, voluntary reserves from retained earnings or share premium. Express provision for the possibility of less than full allotment. Delegation of powers to the board of directors, which may in turn delegate such powers to the executive committee, to establish the terms and conditions of the increase as to all matters not provided for by the shareholders at this general meeting, to take such actions as may be required for implementation thereof, to amend the text of sections 1 and 2 of article 5 of the Bylaws to reflect the new amount of share capital, and to execute such public and private documents as may be necessary to carry out the increase. Application to the appropriate domestic and foreign authorities for admission to trading of the new shares on the Madrid, Barcelona, Bilbao and Valencia Stock Exchanges through Spain's Automated Quotation System (Mercado Continuo) and on the foreign Stock Exchanges on which the shares of Banco Santander are listed in the manner required by each of such Stock Exchanges.

Eight.- Delegation to the board of directors of the power to issue all kinds of fixed-income securities, preferred interests (participaciones preferentes) or debt instruments of a similar nature (including certificates (cédulas), promissory notes and warrants) that are not convertible, depriving of effect, to the extent unused, the delegation in such respect conferred by resolution Eight II) approved by the shareholders acting at the ordinary general shareholders' meeting of 12 April 2019.

Nine.- Director remuneration policy.

Ten.- Director remuneration system: setting of the maximum amount of annual remuneration to be paid to all of the directors in their capacity as such.

Eleven.- Remuneration system: approval of maximum ratio between fixed and variable components of total remuneration of executive directors and other employees belonging to categories with professional activities that have a material impact on the risk profile.

Twelve.- Approval of the application of remuneration plans involving the delivery of shares or share options:

Twelve A. Deferred Multiyear Objectives Variable Remuneration Plan.

Twelve B. Deferred and Conditional Variable Remuneration Plan.

Twelve C. Digital Transformation Award.

Twelve D. Application of the Group's buy-out regulations.

Twelve E. Plan for employees of Santander UK Group Holdings plc. and other companies of the Group in the United Kingdom by means of options on shares of the Bank linked to the contribution of periodic monetary amounts and to certain continuity requirements.

Thirteen.- Authorisation to the board of directors to interpret, remedy, supplement, implement and develop the resolutions approved by the shareholders at the meeting, as well as to delegate the powers received from the shareholders at the meeting, and grant of powers to convert such resolutions into notarial instruments.

Fourteen.- Annual director remuneration report[1].

The call of meeting will be published in the coming days.

Boadilla del Monte (Madrid), 27 February 2020

 

Important Information

 

This document contains certain financial measures that constitute alternative performance measures ("APMs") as defined in the Guidelines on Alternative Performance Measures issued by the European Securities and Markets Authority (ESMA) on 5 October 2015 (ESMA/2015/1415en) and other non-IFRS measures ("Non-IFRS Measures"). The financial measures contained in this document that qualify as APMs and non-IFRS measures have been calculated using the financial information from Santander Group but are not defined or detailed in the applicable financial reporting framework and have neither been audited nor reviewed by our auditors. We use these APMs and non-IFRS measures when planning, monitoring and evaluating our performance. We consider these APMs and non-IFRS measures to be useful metrics for management and investors to facilitate operating performance comparisons from period to period. While we believe that these APMs and non-IFRS measures are useful in evaluating our business, this information should be considered as supplemental in nature and is not meant as a substitute of IFRS measures. In addition, other companies, including companies in our industry, may calculate or use such measures differently, which reduces their usefulness as comparative measures. For further details of the APMs and Non-IFRS Measures used, including its definition or a reconciliation between any applicable management indicators and the financial data presented in the consolidated financial statements prepared under IFRS, please see 2019 4Q Financial Report, published as Relevant Fact on 29 January 2020, as well as the 2018 Annual Financial Report, filed with the Comisión Nacional del Mercado de Valores of Spain (CNMV) on 28 February 2019, These documents are available on Santander's website (www.santander.com).

 

 

[1] Consultative vote.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOAKKOBDABKDABB
Date   Source Headline
18th Dec 20235:17 pmRNSDirector/PDMR Shareholding
18th Dec 20237:05 amRNSDirector/PDMR Shareholding
14th Dec 202311:05 amRNSBuyback programme: transactions 5-13 Dec
13th Dec 20234:41 pmRNSDirector/PDMR Shareholding
13th Dec 20237:02 amRNSOptional early redemption ISIN XS1951093894
11th Dec 202311:24 amRNSSREP Capital Requirements 2024
5th Dec 202311:09 amRNSBuyback programme: transactions 30 Nov – 4 Dec
30th Nov 202311:18 amRNSTotal Voting Rights
30th Nov 202311:12 amRNSBuyback programme: transactions 23-29 Nov
23rd Nov 202311:07 amRNSBuyback programme: transactions 16-22 Nov
22nd Nov 20237:08 amRNSOptional early redemption ISIN XS1692931121
17th Nov 20237:00 amRNSAT1s Contingent Convertible securities
16th Nov 20232:24 pmRNSBuyback programme: transactions 8-15 Nov
16th Nov 202311:06 amRNSBuyback programme: transactions 8-15 Nov
8th Nov 202311:06 amRNSBuyback programme: transactions 31 Oct – 7 Nov
31st Oct 202312:03 pmRNSTotal Voting Rights
31st Oct 202310:14 amRNSBuyback programme: transactions 26–30 Oct
26th Oct 202312:09 pmRNSTotal Voting Rights
26th Oct 202311:05 amRNSBuyback programme: transactions 19 Oct – 25 Oct
25th Oct 20237:00 amRNS3Q 2023 Results Report & Earnings Presentation
25th Oct 20237:00 amRNS3rd Quarter 2023 Results - Press release
19th Oct 202311:08 amRNSBuyback programme: transactions 11 Oct – 18 Oct
18th Oct 202311:11 amRNSNotice of Third Quarter 2023 Results
11th Oct 202311:27 amRNSBuyback programme: transactions 5 Oct – 10 Oct
5th Oct 202311:41 amRNSBuyback programme: transactions 28 Sep – 4 Oct
29th Sep 202311:06 amRNSTotal Voting Rights
27th Sep 20236:31 pmRNSCommencement of a program to repurchase own shares
27th Sep 20237:00 amRNSFurther re dividend approval
27th Sep 20237:00 amRNSDividend approval & buyback program implementation
19th Sep 20237:00 amRNSSantander aligns several models to its strategy
18th Sep 20235:14 pmRNSPerpetual Preferred Securities: rate replacement
31st Aug 20233:09 pmRNSTotal Voting Rights
31st Jul 20232:35 pmRNSTotal Voting Rights
28th Jul 20235:35 pmRNSStress Test Results
28th Jul 202312:56 pmRNSHalf-year Report
26th Jul 20237:00 amRNS1H2023 Results - Press release
26th Jul 20237:00 amRNS1H2023 Results Report & Earnings Presentation
19th Jul 202311:52 amRNSNotice of First Half 2023 Results
30th Jun 20233:28 pmRNSFurther re capital reduction
30th Jun 20232:23 pmRNSTotal Voting Rights
27th Jun 20236:07 pmRNSTotal Voting Rights
27th Jun 20236:03 pmRNSCapital reduction (buy-back programme shares)
31st May 202312:19 pmRNSTotal Voting Rights
19th May 202310:51 amRNSDirector/PDMR Shareholding
18th May 20235:20 pmRNSSantander informs of the MREL determined by SRB
3rd May 202311:38 amRNSCovered Bonds: interest rate replacement
28th Apr 202311:39 amRNSTotal Voting Rights
28th Apr 202311:24 amRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNS1Q2023 Financial report & Earnings presentation
25th Apr 20237:00 amRNS1Q2023 Results - Press release

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.